PDUFA: Oct 19 — Supernus Pharmaceuticals
Supernus Pharmaceuticals [Nasdaq: SUPN] expects an FDA decision under the Prescription Drug User Fee Act (PDUFA) on the approval status of SPN-804, being developed for […]
epilepsy
Icagen and Pfizer Form Three Way Collaboration with Yale To Explore Chronic Pain Remedies
Chronic pain and epilepsy are debilitating disorders that affect millions of individuals in the US and throughout the world.
Hope for Epilepsy Patients, But Treatment Gap Exists Worldwide
An exciting discovery may change the way epilepsy is treated, but if current evidence is any indication, getting the treatment to patients will be a challenge.
Medtronic Files for Pre-Market Approval for Epilepsy Device
Medtronic Deep-Brain Stimulation(DBS) Therapy is designed to treat patients with uncontrollable seizures who do not respond to medication.